Article Information
History
- July 27, 2023.
Article Versions
- You are currently viewing Version 1 of this article (July 27, 2023 - 14:42).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Baike Liu1,2,5,
- Zheran Liu3,5,
- Tianxiang Jiang1,2,5,
- Xiangshuai Gu4,
- Xiaonan Yin1,2,
- Zhaolun Cai1,2,
- Xiaoqiao Zou1,2,
- Lei Dai4,* and
- Bo Zhang1,2,*
- 1Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, the People’s Republic of China
- 2Gastric Cancer Center, West China Hospital, Sichuan University. Chengdu, Sichuan, 610041, the People’s Republic of China
- 3Department of Biotherapy and National Clinical Research Center for Geriatrics, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, the People’s Republic of China
- 4State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, 610041, the People’s Republic of China
- ↵*E-mail: zhangbo_scu{at}scu.edu.cn, daileisklb2012{at}163.com
↵5 These authors contributed equally: Baike Liu, Tianxiang Jiang, Zheran Liu.
Posted July 27, 2023.
Appraising the causal association between gut microbiota and immune-related adverse events: perspectives from a bi-directional Mendelian randomization study
